BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1763231)

  • 1. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
    Bernardeschi P; Bonechi I
    Recenti Prog Med; 1991 Nov; 82(11):588-90. PubMed ID: 1763231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic possibilities in the treatment of the myelodysplasia syndrome].
    Bozóky G; Biliczki F
    Orv Hetil; 1991 May; 132(19):1011-5. PubMed ID: 2027674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors influencing leukemic transformation in myelodysplastic syndrome].
    Borbényi Z; Varga G; Bérczi M; Gurzó M
    Orv Hetil; 1990 Jun; 131(23):1231-6, 1239-40. PubMed ID: 2199892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of refractory anemias. Study of 49 cases].
    Najman A; Harousseau JL; Gorin NC; Duhamel G; André R
    Ann Med Interne (Paris); 1974 Oct; 125(10):703-9. PubMed ID: 4532471
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term myelodysplastic syndrome transformed into blastic leukemia].
    Dimova R; Apostolov P; Popova L
    Vutr Boles; 1988; 27(4):99-103. PubMed ID: 3213032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bernard-Soulier-like functional platelet defect in myelodysplastic syndrome and in acute myeloblastic leukemia associated with trilineage myelodysplasia.
    Hiçsönmez G; Gümrük F; Cetin M; Ozbek N; Tuncer M; Gürsel T
    Turk J Pediatr; 1995; 37(4):425-9. PubMed ID: 8560614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
    Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
    Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [15 patients with myelodysplastic syndrome].
    Dimova R; Apostolov P; Popova L
    Vutr Boles; 1989; 28(3):96-100. PubMed ID: 2773468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ringed sideroblasts in primary myelodysplasia. Leukemic propensity and prognostic factors.
    Vandermolen L; Rice L; Rose MA; Lynch EC
    Arch Intern Med; 1988 Mar; 148(3):653-6. PubMed ID: 3341866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
    Di Giovanni S; Giallonardo P; Costa MP; Carducci P
    Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique.
    Cancer; 1987 Sep; 60(6):1385-94. PubMed ID: 3476180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndromes: natural history and features of prognostic importance.
    Mufti GJ; Galton DA
    Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clonal study of hematopoietic cells].
    Jinnai I
    Rinsho Ketsueki; 1995 Apr; 36(4):273-8. PubMed ID: 7783329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
    Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
    Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA
    Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transient ring sideroblastosis in a human bone marrow allograft (author's transl)].
    Rozmán C; Grañena A; Woessner S; Brugues R; Montserrat E; Hernández-Nieto L; Vives-Corrons JL
    Sangre (Barc); 1977; 22(4):508-14. PubMed ID: 331518
    [No Abstract]   [Full Text] [Related]  

  • 20. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.